Stephens says INOVIO’s proprietary technology and approach involves developing and administering DNA plasmids into affected ...

PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced that its lead DNA medicine candidate, INO-3107, has been granted an ...

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...

Based in Plymouth Meeting, Pennsylvania, Inovio said it had received FDA clearance to begin clinical development of the potential DNA vaccine INO-4800. According to the latest information from the ...

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...

Stock Advisor returns as of August 6, 2024 These events relate to our business plans to develop Inovio's DNA medicines platform, which include clinical and regulatory developments and timing of ...

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus.

Here Are Other Stocks Moving In Monday's Mid-Day Session Avi Kapoor DNA Medicine Focused INOVIO Pharma Efficiencies Implemented By Leadership Will Help De-Risk Its Platform Technology: Analyst ...

Whether you’re looking to learn more about your health traits or dig deep into your familiar roots, having a DNA test done can help you learn a lot about yourself. The good thing is, these tests ...

A new study finds that mitochondria in our brain cells frequently fling their DNA into the cells' nucleus, where the mitochondrial DNA integrates into chromosomes, possibly causing harm.